Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Post by farmermanon Jul 29, 2015 2:03pm
196 Views
Post# 23972597

and more coverage

and more coverageWe believe investors should “sharpen their pencils” on this name as the macro environment (aging demographics) remains very conducive to allow such aforementioned growth.
In a momentum-driven environment, fundamentals are ignored in the short-term. This will change and incredible value is now readily apparent. The company has never been in a better position with ~$60 million in cash, revenue and EBITDA run-rate ~$120/$32 million, expanding EBITDA margin profile (due to Sleep Management) and internal growth of greater than 25%. Those metrics would imply a forward EBITDA of ~$42 million. Based on a recent intra-day price of $0.99, that would imply a valuation of 5.8x versus a peer group average of 10-12x. Pending LOI’s of ~$15 million EBITDA would be further accretive, especially if done all cash, and push the valuation to even more compelling levels


https://beaconsecurities.ca/wordpress/wp-content/uploads/downloads/2015/07/PHM-2015-07-29.pdf

Bullboard Posts